Conexeu Sciences Inc.
Biotechnology · RENO, NV
BiotechnologySEC Form D
Conexeu Sciences Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 21, 2026, reporting $543 raised toward a $1,248,634 offering.
Incorporated in Nevada and based in RENO, NV, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Conexeu Sciences Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- DAVID R BOGARTDirector
- MILES HARRISONExecutive Officer · Director
- AARON FARBERGDirector
- STEPHEN D INOUYEExecutive Officer
- CLAUDIA CHAVEZ-MUNOZExecutive Officer
- JEFF SHARPEDirector
- Z PAUL LORENCDirector
- SEBASTIAN PURCELLDirector
- BRIAN PILCHERExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised